HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of Dynesys posterior stabilization and posterior lumbar interbody fusion for spinal stenosis L4L5.

Abstract
The aim of this prospective randomized study was to compare the radiological and clinical outcome after treatment of lumbar spinal stenosis L4L5 with or without spondylolisthesis, with either posterior lumbar interbody fusion (PLIF) (26 patients) or Dynesys posterior stabilization (27 patients). Demographic characteristics were comparable in both groups. Dynesys stabilization resulted in significantly higher preservation of motion at the index level (p < 0.001), and significantly less (p < 0.05) hypermobility at the adjacent segments. Oswestry Disability Index (ODI) and VAS for back and leg pain improved significantly (p < 0.05) with both methods, but there was no significant difference between groups. Operation time, blood loss, and length of hospital stay were all significantly (p < 0.001) less in the Dynesys group. The latter benefits may be of particular importance for elderly patients, or those with significant comorbidities. Complications were comparable in both groups. Dynesys posterior stabilization was effective for treating spinal stenosis L4L5 with or without spondylolisthesis.
AuthorsShang-Won Yu, Shih-Chieh Yang, Ching-Hou Ma, Chin-Hsien Wu, Cheng-Yo Yen, Yuan-Kun Tu
JournalActa orthopaedica Belgica (Acta Orthop Belg) Vol. 78 Issue 2 Pg. 230-9 (Apr 2012) ISSN: 0001-6462 [Print] Belgium
PMID22696995 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Topics
  • Adult
  • Aged
  • Blood Loss, Surgical (statistics & numerical data)
  • Female
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Pain Measurement
  • Prospective Studies
  • Spinal Fusion (methods)
  • Spinal Stenosis (complications, surgery)
  • Spondylolisthesis (complications, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: